Scientific Program
Note that the proceedings of this conference will be published by Springer as a book (printed and ebook) and will probably appear in June/July 2016.
Conference Program as PDF
Abstracts of presentations on Friday (including posters): abstracts_Friday
Abstracts of presentations on Saturday: abstracts_Saturday
Day 1 Friday, 22 May 2015
08:30 | Paul Werker | Opening the conference | |
08:35 | Jos Aartsen | Welcome from the CEO of UMCG | |
08:40 | Wolfgang Wach & Charles Eaton | Welcome from the International Dupuytren Society & the Dupuytren Foundation | video |
Session 1 | Epidemiology and Patients’ Views | B. Reichert, Z. Szabo | |
08:45 | Zsolt Szabo | Lecture : Treatment of Dupuytren in different countries and the role of FESSH and IFSSH in promoting knowledge for hand surgeons | video |
09:05 | Joseph Dias | The epidemiology of surgical intervention for Dupuytren Contracture in England | video |
09:11 | Bert Reichert | Favorite Options of German Hand Surgeons in the Treatment of Dupuytren Disease | video |
09:17 | Philip Blazar | Trends in Dupuytren’s Treatment in the United States | video |
09:23 | Discussion | ||
09:38 | Wolfgang Wach | The Patient’s View and Needs – An International Survey: Dupuytren Disease | video |
09:44 | Hester Kan | Patients’ preferences for treatment for Dupuytren disease: a Discrete Choice Experiment | |
09:50 | Discussion | ||
Session 2 | Cellular and Extracellular Events |
R. Bank, B. Hinz | |
10:30 | David O’Gorman | Lecture : The extracellular matrix in Dupuytren disease | video |
10:50 | Marianna Kruithof‐de Julio | PDGFR-β targeted modified interferon gamma in Dupuytren disease | |
10:56 | Marike van Beuge | Wnt pathway in Dupuytren disease, connecting pro-fibrotic signals | video |
11:02 | Ian Clark | Biomarkers of post-surgical outcome in Dupuytren disease | video |
11:08 | Jagdeep Nanchahal | Tumour necrosis factor (TNF) as a therapeutic target in Dupuytren disease | video |
11:14 | Discussion | ||
11:30 | David O’Gorman (chair) | Controversies 1: Pathogenesis of Dupuytren Disease: active or passive contracture? | |
11:32 | Jagdeep Nanchahal | Active Contracture | video |
11:37 | Charles Eaton | Passive Contracture | video |
Session 3 | Genetics and Associations |
H. Hennies, R. Ophoff | |
13:00 | Roel Ophoff | Lecture : Genetics in Dupuytren Disease | |
13:20 | Michael Ng | A Large European Genome-wide Association Study Reveals Multiple New Genetic Susceptibility Variants for Dupuytren Disease | video |
13:26 | Kerstin Becker | Meta-analysis of genome-wide imputed GWAS identifies new significant loci in patients with Dupuytren´s disease | |
13:32 | Juanjiangmeng Du | Identification and characterization of functional genetic variants in Dupuytren Disease | |
13:38 | Discussion | ||
13:53 | Dieuwke Broekstra | A systematic review and meta-analysis on the association between Dupuytren disease and diabetes | video |
13:59 | Dieuwke Broekstra | The association between vibration and Dupuytren disease: a comparison between elderly field hockey players and controls | video |
14:05 | Discussion | ||
14:15 | Ilse Degreef (chair) | Controversies 2: The benefit of splinting for Dupuytren contracture | |
14:17 | Adrian Chojnowski | Splinting confers no benefit | video |
14:22 | Wolfgang Wach | Splinting is beneficial | video |
Session 4 | Collagenase Injection |
S Coleman,S Wilbrand | |
15:15 | Larry Hurst | Lecture : Collagenase Treatment – Journey from Bench to Current Advanced Clinical Use | |
15:35 | Paul Werker | Dupuytren Disease in the thumb and first webspace and collagenase treatment | video |
15:41 | Jesper Nordenskjöld | Efficacy of using local anesthesia before collagenase injection in reducing overall pain experience in patients treated for Dupuytren’s contracture: A quasi-randomized study | video |
15:47 | Gary M. Pess | Effect of Delayed Finger Extension on the Efficacy and Safety of Collagenase Clostridium Histolyticum Treatment for Dupuytren Contracture | video |
15:51 | Massimo Corain | The use of a dynamic dorsal splint for Dupuytren Rehabilitation after collagenase | cancelled |
15:57 | Discussion | ||
16:19 | International Dupuytren Society | Dupuytren Award 2014 to Clayton Peimer | |
16:24 | Clayton Peimer | Treatment with Collagenase Clostridium Histolyticum: Five-Year CORDLESS Data | video |
16:30 | Marie Badalamente | Prospective Multicenter, Multinational Study to Evaluate the Safety and Efficacy of Concurrent Collagenase Clostridium Histolyticum Injections to Treat Two Dupuytren Contractures in the Same Hand | video |
16:36 | Marie Badalamente | An Open-label, Controlled Phase 2a Study of the Safety and Efficacy of Injectable Collagenase Clostridium Histolyticum (CCH) in Patients with Adhesive Capsulitis (Frozen Shoulder) | video |
16:42 | David Warwick | Collagenase : what we may never know – a discussion paper | video |
16:48 | Discussion | ||
17:04 | Charles Eaton (chair) | Controversies 3: The best minimally invasive treatment for Dupuytren Disease:PNF or Collagenase? | |
17:06 | Paul Werker | Percutaneous Needle Fasciotomy | video |
17:11 | David Warwick | Collagenase | video |
Day 2 Saturday, 23 May 2015 | |||
Session 5 | Assessment / Percutaneous Needle Fasciotomy |
U. Lanz, G. Pess | |
08:30 | Joseph Dias | MCID for the Patient Evaluation Measure as a Patient Rated Outcome Measure for Dupuytren Contracture | video |
08:36 | Chao Zhou | Predictors of Satisfaction with Hand Function in Patients with Dupuytren Disease | video |
08:42 | Joseph Dias | URAMS as a PROM for Dupuytren Contracture Patients | video |
08:48 | Discussion | ||
09:03 | Gary Pess | Tips and Pearls for Percutaneous Needle Fasciotomy and Collagenase – A Ten Year Personal Experience | video |
09:09 | Margot Vlot | Percutaneous Needle Fasciotomy for secondary or higher recurrence in Dupuytren disease | video |
09:15 | Steven Hovius | Extensive Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy in Patients with Primary Dupuytren Contracture; a Randomized Controlled Trial | video |
09:21 | Discussion | ||
09:37 | Joseph Dias (chair) | Controversies 4: How to treat severe PIP contractures: minimally invasive or surgically? | |
09:41 | Clayton Peimer | Minimally invasive methods | |
09:46 | Caroline Leclercq | Surgical correction | video |
Session 6 | Comparative Studies / Recurrence |
C. Leclercq, D. Elliot |
|
10:45 | David Elliot | Lecture : Treatment of Dupuytren Disease – Where are we now? | |
11:05 | Paul Binhammer | Steroid injection and needle aponeurotomy for Dupuytren disease: long-term follow-up of a randomized controlled trial | video |
11:11 | Eva-Maria Baur | Minimally invasive treatment of Dupuytren: Collagenase vs. PNF |
video |
11:17 | Chao Zhou | Collagenase Clostridium Histolyticum versus Partial Fasciectomy for Dupuytren’s contracture: Early Outcomes From A Multicenter Propensity-Score Matched Study | video |
11:23 | Discussion | ||
11:35 | Jane C Messina | Actual Indications of Continuous Extension Technique (TEC) for Severe Dupuytren Disease | video |
11:41 | Atanu Biswas | Preliminary soft-tissue distraction versus checkrein ligament release after fasciectomy in the treatment of Dupuytren proximal interphalangeal joint contractures | video |
11:47 | Discussion | ||
11:55 | Rinze Zwanenburg | The Palmodigital Spiralling Sheath | |
12:01 | Rosanne Lanting | Clusters in short term disease course in participants with primary Dupuytren Disease | |
12:07 | Discussion | ||
12:15 | Ruud Selles | Recurrence after Treatment for Dupuytren Disease; A consensus-based definition | video |
12:21 | Caroline Leclercq | Recurrence after Dupuytren’s disease:the time factor | |
12:27 | Ilse Degreef | Is Recurrence of Dupuytren Disease Prevented by Full-Thickness Grafting Surgery? | video |
12:33 | Discussion | ||
Session 7 | Related disease & Other Treatments |
R. Selles, R. Shaffer |
|
13:50 | Heinrich Seegenschmiedt | Lecture : Radiotherapy for Early Stage Dupuytren and Ledderhose Disease |
video |
14:10 | Catherine Ball | A Systematic Review Of Non-Surgical Treatments for Early Dupuytren Disease | video |
14:16 | Gary Manley | The Patient’s View and Needs – An International Survey: Ledderhose Disease | video |
14:22 | Discussion | ||
14:32 | Gloria Sue | Use of Acellular Dermal Matrix in Dupuytren Disease | video |
14:38 | Ilse Degreef | In vivo RCT Tension versus compression on Dupuytren | video |
14:44 | Discussion | ||
14:54 | Mels van Driel | Lecture : Peyronie’s Disease Treatment: The State of the Art |
video |
Symposia | Focus on Research |
J. Dias | |
15:35 | Joseph Dias | Introduction to the symposia | video |
15:40 | David O’Gorman | Basic Research: important prerequisites for future studies | D. O’Gorman video |
Ruud Bank | We need better methodologies for Dupuytren research | video | |
Dominic Furniss | Requirements for genetic research and novel ways to attract funding | video | |
16:30 | Maria Badalamente | Clinical Research: international collaboration to execute high powered clinical trials | M. Badalamente video |
Joseph Dias | Patient Rated Outcome Measures (PROMS) | video | |
Charles Eaton | International Dupuytren Data Bank (IDDB) | video | |
Steve Coleman | Clinical Research in Australia | video | |
17:20 | Paul Werker | Closing remarks |